Literature DB >> 17284293

Modulation of AMPA receptors in cultured cortical neurons induced by the antiepileptic drug levetiracetam.

Irene Carunchio1, Massimo Pieri, Maria Teresa Ciotti, Federica Albo, Cristina Zona.   

Abstract

PURPOSE: The present study explores the hypothesis that the antiepileptic mechanism of action of levetiracetam (LEV) is related to effects on alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor channels in mouse cortical neurons in culture.
METHODS: The neurons were subjected to the whole-cell configuration of the patch-clamp recording technique and were 8-12 days old in culture.
RESULTS: Kainate elicited concentration-dependent (EC(50)= 80 microM) inward currents in all the patched cells. LEV (5-200 microM) itself did not induce inward or outward currents on all patched neurons, whereas it was effective on the kainate- and AMPA-induced current because it significantly decreased the amplitude of these currents. LEV was also able to significantly decrease the total membrane conductance during kainate perfusion, indicating that its effect was not dependent on the cellular voltage membrane potential. Further evidence that LEV modulated the ionotropic non-NMDA receptors came from the analysis of miniature excitatory postsynaptic currents (mEPSCs). In fact, LEV significantly decreased both the amplitude and the frequency of mEPSCs, as shown by the relative cumulative distributions.
CONCLUSIONS: These results reveal that AMPA receptors are modulated by LEV because a significant decrease in the kainate- and AMPA-induced currents and a decrease in amplitude and in frequency of mEPSCs have been observed in cortical neurons in culture. The described effect of LEV on AMPA receptors in cortical neurons is probably due to the etheromeric composition of the receptors and may be considered as a possible new antiepileptic mechanism of action.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17284293     DOI: 10.1111/j.1528-1167.2006.00973.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  17 in total

1.  New treatment options in status epilepticus: a critical review on intravenous levetiracetam.

Authors:  Eugen Trinka; Judith Dobesberger
Journal:  Ther Adv Neurol Disord       Date:  2009-03       Impact factor: 6.570

2.  Is levetiracetam different from other antiepileptic drugs? Levetiracetam and its cellular mechanism of action in epilepsy revisited.

Authors:  Rainer Surges; Kirill E Volynski; Matthew C Walker
Journal:  Ther Adv Neurol Disord       Date:  2008-07       Impact factor: 6.570

3.  Gene expression profiles of APP and BACE1 in Tg SOD1G93A cortical cells.

Authors:  Ornella Spadoni; Alessio Crestini; Paola Piscopo; Lorenzo Malvezzi-Campeggi; Irene Carunchio; Massimo Pieri; Cristina Zona; Annamaria Confaloni
Journal:  Cell Mol Neurobiol       Date:  2009-02-13       Impact factor: 5.046

4.  Levetiracetam inhibits glutamate transmission through presynaptic P/Q-type calcium channels on the granule cells of the dentate gyrus.

Authors:  Chun-Yao Lee; Chih-Chuan Chen; Horng-Huei Liou
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

Review 5.  Levetiracetam in childhood epilepsy.

Authors:  Alberto Verrotti; Ebe D'Adamo; Pasquale Parisi; Francesco Chiarelli; Paolo Curatolo
Journal:  Paediatr Drugs       Date:  2010-06       Impact factor: 3.022

6.  Effects of levetiracetam on astroglial release of kynurenine-pathway metabolites.

Authors:  Kouji Fukuyama; Motohiro Okada
Journal:  Br J Pharmacol       Date:  2018-10-06       Impact factor: 8.739

7.  A double-blind, placebo-controlled trial assessing the efficacy of levetiracetam extended-release in very heavy drinking alcohol-dependent patients.

Authors:  Joanne B Fertig; Megan L Ryan; Daniel E Falk; Raye Z Litten; Margaret E Mattson; Janet Ransom; William J Rickman; Charles Scott; Domenic Ciraulo; Alan I Green; Nassima A Tiouririne; Bankole Johnson; Helen Pettinati; Eric C Strain; Eric Devine; Mary F Brunette; Kyle Kampman; David A Tompkins; Robert Stout
Journal:  Alcohol Clin Exp Res       Date:  2012-02-10       Impact factor: 3.455

8.  The effects of levetiracetam on alcohol consumption in alcohol-dependent subjects: an open label study.

Authors:  Ofra Sarid-Segal; Joanna Piechniczek-Buczek; Clifford Knapp; Maryam Afshar; Eric Devine; Laurie Sickles; Emma Uwodukunda; Courtney Richambault; Jillian Koplow; Domenic Ciraulo
Journal:  Am J Drug Alcohol Abuse       Date:  2008       Impact factor: 3.829

9.  In the rat maximal dentate activation model of partial complex epilepsy, the anticonvulsant activity of levetiracetam is modulated by nitric oxide-active drugs.

Authors:  Pierangelo Sardo; Stefania D'Agostino; Valerio Rizzo; Fabio Carletti; Gioacchino Lonobile; Giuseppe Ferraro
Journal:  J Neural Transm (Vienna)       Date:  2009-05-12       Impact factor: 3.575

Review 10.  Selecting Rational Drug Combinations in Epilepsy.

Authors:  Bassel Abou-Khalil
Journal:  CNS Drugs       Date:  2017-10       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.